Back

Identifying protein biomarkers and therapeutic targets in psoriasis through integrative genomic, proteomic and transcriptomic analysis

Meena, D.; Chalitsios, C. V.; Huang, J.; Meena, N.; Wu, S.; Smith, A.; Antonatos, C.; Vasilopoulos, Y.; Yarmolinsky, J.; Gill, D.; Dehghan, A.; Tsilidis, K. K.; Tzoulaki, I.

2026-07-13 genetic and genomic medicine
10.64898/2026.07.09.26357649 medRxiv
Show abstract

Plasma proteins are promising biomarkers and potential drug targets in psoriasis. We conducted a two-sample Mendelian randomisation analysis integrating protein quantitative trait loci from UK Biobank and deCODE genetics with a psoriasis GWAS meta-analysis of 36,466 cases. To strengthen causal inference, we performed colocalisation analyses to evaluate shared genetic signals and applied summary data-based MR (SMR) with HEIDI testing using expression quantitative trait loci to exclude linkage-driven associations. After correction for multiple testing, 78 circulating proteins showed genetically predicted associations with psoriasis, with 27 demonstrating strong colocalisation (PPH4>80%). Triangulation prioritised 12 Tier 1 proteins, STX4, FLT3, NFKB1, IL18, PRSS53, SPAG1, SGSH, PLAT, RALB, TNFSF11, SPHK2, and STAT3, supported by consistent effects and no heterogeneity. Network profiling and Genome for REPositioning analyses assessed biological connectivity and druggability, revealing enrichment in anatomical therapeutic chemical groups L and B. Single-cell RNA sequencing confirmed cell-type-specific expression and modulation following IL-23 blockade.

Matching journals

The top 6 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.